News

People with diseases caused by rare mutations have fewer options and poorer prospects than other patients despite rapid ...
Further genetic improvements are needed to meet the challenges of modern agriculture, according to scientists hosting a ...
A team was able to edit the DNA of Lactobacillus strains directly without a template from other organisms. This technique is indistinguishable from natural variation and enabled the researchers to ...
Sickle cell has been overlooked for far too long. Fortunately, there are new breakthroughs in sickle cell treatment that you ...
Prime Medicine’s modular editing tech may lower off-target risk, but key data and funding milestones remain ahead. Find out ...
The CRISPR company is laying off about a third of its employees and stopping work on an experimental lupus treatment in a bid ...
Here’s what Catholics should know about the dire wolves and what the Church might have to say about “resurrecting” extinct species of animals.
Genomics company, Integrated DNA Technologies, is rewriting the future of genomics, pioneering new innovations in a bold move ...
Crispr Therapeutics is an emerging gene editing company focused on the development of Crispr/Cas9-based therapeutics. The company's proprietary platform specializes in clustered regularly interspaced ...
Biotech firms are engineering smarter, safer gene delivery systems to enhance the safety and efficacy of genetic medicines.
These names in the biotech sector are seeing a substantial increase in search activity today, as determined by InvestingChannel. They include: ...
Pfizer (NYSE:PFE) is a global pharmaceutical giant that has long been a cornerstone of medical innovation and today boasts a ...